Skip to main content
. 2014 Aug 8;9(9):1577–1585. doi: 10.2215/CJN.12691213

Table 4.

Characteristics of matched patients on pre-emptive RRT compared with matched patients who did not receive RRT

Characteristic Pre-emptive RRT Non-RRT P Value SMD
Age (yr) 64.0 [56.0–76.0] 67.0 [55.0–75.0] 0.92 −0.5
Men 44/67 (65.7) 46//67 (68.7) 0.03 −6.4
CKD 10/66 (14.9) 7/67 (10.4) 0.61 13.6
Operative admission 33/67 (49.3) 28/67 (41.8) 0.52 15.1
Emergency admission 56/67 (83.6) 58/67 (86.6) 0.79 −8.4
Admitted froma 0.92
 Operating room or recovery room 32/67 (47.8) 28/67 (41.8)
 Emergency room 14/67 (20.9) 21/67 (31.3)
 Ward 15/67 (22.4) 14/67 (20.9)
 Other 6/67 (9.0) 4/67 (6.0)
SAPS II score 45.0 [35.0–59.0] 41.0 [32.0–58.0] 0.11 13.5
SAPS II score without age and renal components 24.0 [16.0–30.0] 24.0 [17.0–30.0] 0.83 −0.4
SOFA score, first 24 h 10.0 [8.0–13.0] 9.0 [7.0–12.0] 0.24 16.9
SOFA score, maximum 12.0 [9.0–14.0] 9.0 [8.0–13.0] 0.001 52.6
Mechanical ventilation (ICU stay) 58/67 (86.8) 47/67 (70.1) 0.04 20.6
Severe sepsis until day 5 31/67 (46.3) 29/67 (43.3) 0.03 6.0
AKI before RRT or within days 1–5 55/67 (82.1) 59/67 (88.1) 0.13 −16.9
Highest AKI stage before RRT or within 24 h of ICU admission (patients not on RRT)a 0.35
 Stage 1 15/67 (22.4) 15/67 (22.4)
 Stage 2 21/67 (31.3) 23/67 (34.3)
 Stage 3 19/67 (28.4) 20/67 (29.9)
Treatment restrictionsb 16/66 (24.2) 29/67 (43.3) 0.02 −41.2
At ICU admission
 Vasoactives 57/67 (85.1) 60/67 (89.6) 0.61 −13.6
 Severe sepsis 28/67 (41.8) 23/67 (34.3) 0.47 15.5
 Highest norepinehprine dose within first 24 h (μg/kg per minute) 0.22 [0.06–0.44] 0.18 [0.07–0.35] 0.28 5.0
 Cumulative urine output within the first 24 h (ml) 865 [460–1760] 1135 [546–1720] 0.78 0.9
 First creatinine (mg/dl) 1.6 [1.2–2.2] 1.4 [1.0–2.7] 0.95 −2.5
 First lactate (mmol/L) 2.8 [1.5–5.8] 2.5 [1.3–5.2] 0.71 7.7
 Received diuretics 35/64 (54.7) 30/65 (46.2) 0.31 17.1
90-d mortality 18/67 (26.9) 33/67 (49.3) 0.01 −47.4

Data are expressed as median [interquartile range] or number/total number (percentage). SMD, standardized mean difference.

a

Comparison across groups with marginal homogeneity test.

b

Treatment restrictions include one or several of the following restrictions: (1) do not resuscitate, (2) do not increase the intensity of treatment, and (3) withdrawal of intensive care.